Regenxbio (RGNX) Cash from Operations Growth (1y) (2015 - 2025)
Regenxbio (RGNX) Cash from Operations Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
-65.35% |
| Date | Value |
|---|
| Dec 31, 2025 |
-65.35% |
| Sep 30, 2025 |
-38.01% |
| Jun 30, 2025 |
-8.45% |
| Mar 31, 2025 |
160.64% |
| Dec 31, 2024 |
22.41% |
| Sep 30, 2024 |
17.93% |
| Jun 30, 2024 |
3.86% |
| Mar 31, 2024 |
31.47% |
| Dec 31, 2023 |
-3.53% |
| Sep 30, 2023 |
2.08% |
| Jun 30, 2023 |
23.36% |
| Mar 31, 2023 |
-44.73% |
| Dec 31, 2022 |
-111.53% |
| Sep 30, 2022 |
-18.71% |
| Jun 30, 2022 |
-71.18% |
| Mar 31, 2022 |
-26.93% |
| Dec 31, 2021 |
765.25% |
| Sep 30, 2021 |
-16.57% |
| Jun 30, 2021 |
-67.81% |
| Mar 31, 2021 |
-23.82% |
